Climb Bio, Inc. (CLYM) Misses Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts CLYM Hot Sheet
Join SI Premium – FREE
Climb Bio, Inc. (NASDAQ: CLYM) reported Q4 EPS of ($0.26), $0.07 worse than the analyst estimate of ($0.19).
For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Software catches a bid as investors rotate ahead of Palantir earnings
- RBC Capital Starts Climb Bio (CLYM) at Outperform
- Hess Midstream Partners LP (HESM) Tops Q2 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
